骨形态发生蛋白结合后外侧融合在腰椎退行性疾病手术中的应用

doi:10.6040/j.issn.1671-7554.0.2019.297

摘要/Abstract

摘要： 目的评价骨形态发生蛋白(BMP)结合后外侧融合术(PLF)治疗腰椎退行性疾病的临床疗效。方法回顾2014年1月至2017年11月在山东大学齐鲁医院(青岛)因腰椎退行性疾病行后外侧融合术(PLF)患者66例,其中男34例,女32例, 36~79岁,平均(54.5±14.2)岁。单节段、双节段、三节段患者分别为26例、28例、12例;腰椎管狭窄症45例,腰椎滑脱症(I°)11例,腰椎间盘突出症(极外侧)10例。主要临床表现为腰痛、下肢疼痛和下肢麻木。行经微创通道Wiltse入路减压,磨钻制备植骨床,后外侧植骨,钉棒系统固定。单纯自体骨植骨23侧,自体骨+同种异体骨33侧,自体骨+BMP 32侧,同种异体骨+BMP 19侧,自体骨+同种异体骨+BMP 25侧,常规左侧应用BMP,其中有13例双侧均应用BMP。临床疗效评估采用Oswestry功能障碍指数(ODI)、疼痛视觉模拟评分(VAS);参照Suk标准评估融合情况。结果随访时间12~24个月,平均(14.7±3.2)个月。术后1年VAS评分、ODI均有改善,未发生临床并发症。随着术后随访时间延长,不同植骨材料组融合率均逐渐增高,术后3、6个月,1年融合率,单纯自体骨侧分别为52%、65%、96%,自体骨+同种异体骨侧52%、64%、94%,自体骨+BMP侧分别为84%、88%、94%,同种异体骨+BMP侧为84%、89%、95%,自体骨+同种异体骨+BMP侧分别为84%、88%、96%。结论 PLF治疗腰椎退行性疾病融合率高、组织损伤小,是腰椎融合方式的一个选择及补充。BMP可提高PLF近期随访的融合率,但远期随访时融合率无明显差别。

关键词: 骨形态发生蛋白, 后外侧融合, 腰椎退行性疾病, Wiltse入路

Abstract: Objective To evaluate the clinical efficacy of bone morphogenetic protein(BMP)combined with posterolateral fusion(PLF)in the treatment of lumbar degenerative diseases. Methods The clinical data of 66 patients with lumbar degenerative diseases who underwent PLF during Jan. 2014 and Nov. 2017 were retrospectively analyzed, including 34 males and 32 females, aged 36-79 years, average(54.5±14.2)years. The disease involved single segment, double segments and three segments in 26, 28 and 12 cases, respectively. Lumbar spinal stenosis, lumbar spondylolisthesis(I°)and far lateral lumber disc herniation occurred in 45, 11 and 10 cases, respectively. The main clinical manifestations were low back pain, lower extremity pain and anesthesia. After decompression through the minimally invasive Wiltse approach, bone grafting bed was prepared by high-speed burr. PLF was performed on 23 sides with autologous bone alone, 33 sides with autologous and allogeneic bone, 32 sides with autologous bone and BMP, 19 sides with alloge- 山东大学学报 (医学版)57卷5期 -夏海鹏,等.骨形态发生蛋白结合后外侧融合在腰椎退行性疾病手术中的应用 \=-neic bone and BMP, and 25 sides with autologous and allogeneic bone and BMP. BMP was routinely used in the left side, and used in both sides in 13 patients. The clinical efficacy was evaluated with Oswestry disability index(ODI)and visual analogue scale(VAS), and the fusion rate was evaluated with Suk. Results The patients were followed up for 12-24 months, average(14.7±3.2)months. One year after surgery, VAS score and ODI were significantly improved, and no clinical complications occurred. As the postoperative follow-up prolonged, the fusion rate 3 months, 6 months and 1 year after surgery for the autologous bone sides was 52%, 65% and 96%, for the autologous bone + allogeneic bone sides was 52%, 64%, 94%, for the autologous bone + BMP sides was 84%, 88% and 94%, for the allogeneic bone + BMP sides was 84%, 89%, 95%, and for the autologous bone + allogeneic bone + BMP sides was 84%, 88% and 96%, respectively. Conclusion PLF is safe, effective and minimal invasive in the treatment of lumbar degenerative diseases. BMP can improve the short-term fusion rate of PLF, but does not affect the long-term fusion rate.

Key words: Bone morphogenetic protein, Posterolateral fusion, Lumbar degenerative disease, Wiltse approach

中图分类号:

R681.5

夏海鹏,郑燕平,周超,殷军,丛伟. 骨形态发生蛋白结合后外侧融合在腰椎退行性疾病手术中的应用[J]. 山东大学学报 (医学版), 2019, 57(5): 62-66.

XIA Haipeng, ZHENG Yanping, ZHOU Chao, YIN Jun, CONG Wei. Application of bone morphogenetic protein combined with posterolateral fusion in the treatment of lumbar degenerative diseases[J]. Journal of Shandong University (Health Sciences), 2019, 57(5): 62-66.

参考文献

[1] Hibbs RA. An operation for progressive spinal deformities: a preliminary report of three cases from the service of the orthopaedic hospital 1911[J]. Clin Orthop Relat Res, 2007, 460: 17-20.
[2] Albee FH. Transplantation of a portion of the tibia into the spine for Pott’s disease: a preliminary report 1911[J]. Clin Orthop Relat Res, 2007, 460: 14-16.
[3] Cleveland M, Bosworth DM, Thompson FR. Pseudarthrosis in the lumbosacral spine[J]. J Bone Joint Surd Am, 1948, 30A(2): 302-312.
[4] Watkins MB. Posterolateral fusion of the lumbar and lumbosacral spine[J]. J Bone Joint Surg(Am), 1953, 35A(4): 1014-1018.
[5] Endler P. Outcomes of posterolateral fusion with and without instrumentation and of interbody fusion for isthmic spondylolisthesis: a prospective study[J]. J Bone Joint Surg AM, 2017, 99(9): 743-752.
[6] Suk SI, Lee CK, Kim WJ, et al. Adding posterior lumbar interbody fusion to pedicle screw fixation posteolateral fusion after decompression in spondylolytic spondylolisthesis[J]. Spine,1997, 22(2): 210-219.
[7] 张铭华, 董靖, 卢曼鹏. Wiltse 手术入路和后正中入路经椎间孔腰椎椎体间融合术治疗退变性腰椎滑脱[J]. 中华创伤杂志, 2012, 28(7): 624-628. ZHANG Minghua, DONG Jing, LU Manpeng. Wiltse approach and posterior midline approach transforaminal lumbar interbody fusion for degenerative lumbar spondylolisthesis: a comparative study[J]. Chinese Journal of Trauma, 2012, 28(7): 624-628.
[8] 于亮, 徐荣明, 马维虎.TLIF 与 PLIF 治疗腰椎退行性疾病疗效的Meta分析[J]. 中国脊柱脊髓杂志, 2013, 23(10): 886-890. YU Liang, XU Rongming, MA Weihu. Meta-analysis of outcomes of transforaminal lumbar interbody fusion versus posterior lumbar interbody fusion for degenerative lumbar diseases[J]. Chinese Journal of Spine and Spinal Cord, 2013, 23(10): 886-890.
[9] 王大伟, 韩士章, 张佐伦, 等. 腰椎后外侧融合术[J]. 中国矫形外科杂志, 2004, 12(5): 374-376. WANG Dawei, HAN Shizhang,ZHANG Zuolun, et al. Posterolateral fusion[J]. Orthopedic Journal of China, 2004, 12(5): 374-376.
[10] Haro H, Maekawa S, Hamada Y. Prospective analysis of clinical evaluation and self-assessment by patient after decompression surgery for degenerative lumbar canal stenosis[J]. Spine J, 2008, 8(2): 380-384.
[11] Whang PG, Wang JC. Bone graft substitutes for spinal fusion[J]. Spine J, 2003, 3(2): 155-165.
[12] Burkus JK, Sandhu HS, Gornet MF. Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft[J]. Spine, 2006, 31(7): 775-781.
[13] John A, McCulloch, Paul H, et al. Essentials of spinal microsurgery[M]. Philadelphia: Lippincott, 1999, 81(7): 1050.
[14] Urist MR. Bone: formation by autoinduction[J]. Science, 1965, 150(698): 893- 899.
[15] Jun SH, Lee EJ, Jang TS, et al. Bone morphogenic protein-2(BMP-2)loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering[J]. J Mater Sci Mater Med, 2013, 24(3): 773-782.
[16] Park JS, Yang HN, Jeon SY, et al. Osteogenic differentiation of human mesenchymal stem cells using RGD-modified BMP -2 coated microspheres[J]. Biomaterials, 2010, 31(24): 6239-6248.
[17] 雷建平, 徐昊, 张克良. rhBMP-2骨修复材料在后路腰椎内固定植骨融合术中应用[J].中国矫形外科杂志, 2018, 26(5): 390-394. LEI Jianping, XU Hao, ZHANG Keliang. Application of bone repair material containing recombinant human bone morphogenetic protein-2 in instrumented posterior lumbar interbody fusion[J]. Orthopedic Journal of China, 2018, 26(5): 390-394.
[18] 何保华, 朱伟, 夏虹,等. BMP-2混合自体髂骨植骨在寰枢椎脱位后路复位固定融合术中的应用[J]. 中国骨与关节损伤杂志, 2016, 31(9): 897-900. HE Baohua, ZHU Wei, XIA Hong, et al. Effect analysis of biological bone material mixed with autologous bone in atlantoaxial dislocation by posterior fixation and bone graft with fusion[J]. Chinese Journal of Bone and Joint Injury, 2016, 31(9): 897-900.
[19] 田海军. 两种融合手术治疗腰椎滑脱症的影像学及临床疗效比较研究[J]. 中华骨科杂志, 2009, 29(5): 445-449. TIAN Haijun. Radiological and clinical outcomes of posterolateral fusion versus posterior lumbar interbody fusion for spondylolisthesis[J]. Chinese Journal of Orthopaedics, 2009, 29(5): 445-449.
[20] 蒋杰, 陈亮, 顾勇, 等. 骨形态发生蛋白2载体材料在脊柱融合方面的研究与应用[J]. 中国组织工程研究, 2015, 19(52): 8487-8491. JIANG Jie, CHEN Liang, GU Yong, et al. Bone morphogenetic protein-2 carrier materials in the spinal fusion[J]. Chinese Journal of Tissue Engineering Research, 2015, 19(52): 8487-8491.
[21] Chadi A, Tannoury, Howard S. Complications with the use of bone morphogenetic protein 2(BMP-2)in spine surgery[J]. The Spine Journal, 2014, 14(3): 552-559.
[22] Dong J, Rong L, Feng F, et al. Unilateral pedicle screw fixation through a tubular retractor via the Wiltse approach compared with conventional bilateral pedicle screw fixation for single-segment degenerative lumbar instability: a prospective randomized study[J]. J Neurosurg Spine, 2014, 20(1): 53-55.
[23] Roca J, Iborra M, Cavanilles Walker JM, et al. Direct repair of spondylolysis using a new pedicle screw hook fixation: clinical and CT-assessed study: an analysis of 19 patients[J]. J Spinal Disord, 2005, 18(Suppl): 82-89.
[24] Noshchenko A, Hoffecker L, Lindley EM, et al. Perioperative and long-term clinical outcomes for bone morphogenetic protein versus iliac crest bone graft for lumbar fusion in degenerative disk disease: systematic review with meta-analysis[J]. J Spinal Disord Tech, 2014, 27(3): 117-135.
[25] Singh K, Nandyala SV, Marquez-Lara A, et al. Epidemiological trends in the utilization of bone morphogenetic protein in spinal fusions from 2002 to 2011[J]. Spine, 2014, 39(6): 491-496.
[26] 周超, 田永昊, 郑燕平, 等. 经椎间孔腰椎椎体间融合术治疗单节段退变性腰椎滑脱的疗效分析[J]. 山东大学学报(医学版), 2015, 53(12): 71-75. ZHOU Chao, TIAN Yonghao, ZHENG Yanping, et al. The clinical efficacy of mini-invasive transforaminal lumbar interbody fusion(tlif)for the treatment of lumbar spondylolisthesis[J]. Journal of Shandong University(Health Sciences), 2015, 53(12): 71-75.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed